Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial...

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Aging Research

Background:

• Granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) show potential for post-myocardial infarction (MI) repair by enhancing cardiac mechanisms and reducing cardiomyocyte death.
• Age-related changes in repair pathways suggest that the efficacy of G-CSF and SCF may be diminished in older individuals.

Purpose of the Study:

• To investigate the hypothesis that the therapeutic efficacy of G-CSF and SCF is impaired in aged rats compared to young adult rats following myocardial infarction.

Main Methods:

• Myocardial infarction was induced in young (6-month-old) and old (20-month-old) rats via permanent ligation of the left coronary artery.
• G-CSF and SCF therapy was administered, and cardiac function, left ventricular remodeling, infarct size, cardiomyocyte hypertrophy, and apoptosis were assessed.

Main Results:

• In young rats, G-CSF/SCF therapy improved cardiac function, reduced left ventricular dilation, decreased infarct size, and lessened cardiomyocyte hypertrophy.
• These beneficial effects were absent in aged rats, despite effective mobilization of bone marrow cells and comparable c-Kit(+) cell presence in the myocardium.
• While the G-CSF/SCF cocktail reduced cardiomyocyte apoptosis in both age groups, the reduction was significantly less in old rats, with apoptosis rates remaining high.

Conclusions:

• G-CSF and SCF therapy lacks therapeutic efficacy in aged rats after myocardial infarction, primarily due to an inability to sufficiently offset periinfarct cardiomyocyte apoptosis.
• These findings raise concerns about the effectiveness of novel cytokine therapies in elderly populations who are at higher risk for adverse outcomes after MI.